The Role of Environmental Factors in the Etiology of Lymphoma

REFERENCES

• American Cancer Society. Cancer Facts and Figures. 2006, Atlanta www.cancer.org
   Google Scholar
• Hartge P., Devesa S. S. Quantification of the impact of known risk factors on time trends in non-Hodgkin lymphoma incidence. Cancer Res 1992; 52: 5566s–5569s
   PubMed Web of Science ®Google Scholar
• Holford T. R., Zheng T., Mayne S. T., McKay L. A. Time trends of non-Hodgkin lymphoma: are they real? What do they mean?. Cancer Res 1992; 52: 5443s–5446s
   PubMed Web of Science ®Google Scholar
• Banks P. M. Changes in diagnosis of non-Hodgkin lymphomas over time. Cancer Res 1992; 52(19)5453s–5455s
   PubMed Web of Science ®Google Scholar
• Harris N. L., Jaffe E. S., Diebold J., Flandrin G., Muller-Hermelink H. K., Vardiman J., Lister T. A., Bloomfield C. D. The World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the clinical advisory committee meeting, Airlie House, Virginia, November 1997. Ann Oncol 1999; 10(12)1419–1432
   PubMed Web of Science ®Google Scholar
• SEER Cancer Stat Fact Sheets. National Cancer Institute. 2006, Bethesda http://seer.cancer.gov
   Google Scholar
• Groves F. D., Linet M. S., Travis L. B., Devesa S. S. Cancer surveillance series: non-Hodgkin lymphoma incidence by histologic subtype in the United States from 1978 through 1995. J Natl Cancer Inst 2000; 92(15)1240–1251
   PubMed Web of Science ®Google Scholar
• GLOBOCAN 2002 database, International Agency for Research on Cancer, World Health Organization www-dep.iarc.fr
   Google Scholar
• Filipovich A. H., Mathur A., Kamat D., Shapiro R. S. Primary immunodeficiencies: genetic risk factors for lymphoma. Cancer Res 1992; 52(19)5465s–5467s
   PubMed Web of Science ®Google Scholar
• Kinlen L. Immunosuppressive therapy and acquired immunological disorders. Cancer Res 1992; 52(19)5474s–5476s
   PubMed Web of Science ®Google Scholar
• Canioni D., Jabado N., MacIntyre E., Patey N., Emile J. F., Brousse N. Lymphoproliferative disorders in children with primary immunodeficiencies: immunological status may be more predictive of the outcome than other criteria. Histopathology 2001; 38(2)146–159
   PubMed Web of Science ®Google Scholar
• Askling J., Klareskog L., Hjalgrim H., Baecklund E., Björkholm M., Ekbom A. Do steroids increase lymphoma risk? A case-control study of lymphoma risk in polymyalgia rheumatica/giant cell arteritis. Ann Rheum Dis 2005; 64(12)1765–1768
   PubMed Web of Science ®Google Scholar
• Opelz G., Dohler B. Lymphomas after solid organ transplantation: a collaborative transplant study report. Am J Transplant 2004; 4(2)222–230
   PubMed Web of Science ®Google Scholar
• Selik R. M., Starcher E. T., Curran J. W. Opportunistic diseases reported in AIDS patients: frequencies, associations, and trends. AIDS 1987; 1(3)175–182
   PubMed Web of Science ®Google Scholar
• Dal Maso L., Franceschi S. Epidemiology of non-Hodgkin lymphomas and other haemolymphopoietic neoplasms in people with AIDS. Lancet Oncol 2003; 4(2)110–119
   PubMed Web of Science ®Google Scholar
• Cortes J., Thomas T., Rios A., Koller C., O'Brien S., Jeha S., Faderl S., Kantarjian H. Hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone and highly active antiretroviral therapy for patients with acquired immunodeficiency syndrome-related Burkitt lymphoma/leukemia. Cancer 2002; 94(5)1492–1499
   PubMed Web of Science ®Google Scholar
• Human immunodeficiency viruses and human T-cell lymphotropic viruses. International Agency for Research on Cancer monographs on the evaluation of carcinogenic risks to humans. IARC Press, Lyon 1996; vol 67
   Google Scholar
• Laurence J., Astrin S. M. Human immunodeficiency virus induction of malignant transformation in human B lymphocytes. Proc Natl Acad Sci USA 1991; 88(17)7635–7639
   PubMed Web of Science ®Google Scholar
• Carbone A., Gloghini A. AIDS-related lymphomas: from pathogenesis to pathology. Br J Haematol 2005; 130(5)662–670
   PubMed Web of Science ®Google Scholar
• Bower M., Gazzard B., Mandalia S., Newsom-Davis T., Thirlwell C., Dhillon T., Young A. M., Powles T., Gaya A., Nelson M., Stebbing J. A prognostic index for systemic AIDS-related non-Hodgkin lymphoma treated in the era of highly active antiretroviral therapy. Ann Intern Med. Apr 18, 2006; 144(8)620, erratum appears in[summary for patients in Ann Intern Med. 2005 Aug 16;143(4):I28; PMID: 16103466]. Ann Intern Med 2005, 143(4), 265–273
   Web of Science ®Google Scholar
• Epstein M. A., Achong B. G., Barr Y. M. Virus particles in cultured lymphoblasts from Burkitt's lymphoma. Lancet 1964; 15: 702–703
   Web of Science ®Google Scholar
• Mueller N., Grufferman S. Cancer Epidemiology and Prevention, 3rd edition. Oxford University Press, Oxford 2004
   Google Scholar
• Thorley-Lawson D. A., Gross A. Mechanisms of disease: persistence of the Epstein-Barr virus and the origins of associated lymphomas. N Engl J Med 2004; 350(13)1328–1337
   PubMed Web of Science ®Google Scholar
• Murphy E. L., Figueroa J. P., Gibbs W. N., Holding-Cobham M., Cranston B., Malley K., Bodner A. J., Alexander S. S., Blattner W. A. Human T-lymphotropic virus type I (HTLV-1) seroprevalence in Jamaica: I. demographic determinants. Am J Epidemiol 1991; 133(11)1114–1124
   PubMed Web of Science ®Google Scholar
• Jaffe E. S., Harris N. L., Stein H., Vardiman J. W. World Health Organization Classification of Tumours: Tumours of the Haematopoietic and Lymphoid Tissues. International Agency for Research on Cancer, Lyon 2001
   Google Scholar
• Wattel E., Vartanian J. P., Pannetier C., Wain-Hobson S. Clonal expansion of human T-cell leukemia virus type I-infected cells in asymptomatic and symptomatic carriers without malignancy. J Virology 1995; 69(5)2863–2868
   PubMed Web of Science ®Google Scholar
• Sibon D., Gabet A. S., Zandecki M., Pinatel C., Thête J., Delfau-Larue M. H., Rabaaoui S., Gessain A., Gout O., Jacobson S., Mortreux F., Wattel E. HTLV-1 propels untransformed CD4+ lymphocytes into the cell cycle while protecting CD8+ cells from death. J Clin Invest 2006; 116(4)974–983
   PubMed Web of Science ®Google Scholar
• Hussell T., Isaacson P., Crabtree J., Spencer J. The response of cells from low-grade B-cell gastric lymphoma of mucosa-associated lymphoma tissue to Helicobacter pylori. Lancet 1993; 342(8871)571
   PubMed Web of Science ®Google Scholar
• Jaffe E. S. Common threads of mucosa-associated lymphoid tissue lymphoma pathogenesis: from infection to translocation. J Natl Cancer Inst 2004; 96(8)571–573
   PubMed Web of Science ®Google Scholar
• Houghton J., Fox J. G., Wang T. C. Helicobacter pylori and other causes of gastric ulceration. J Gastroenterol Hepatol 2002; 17(4)495–502
   PubMedGoogle Scholar
• Cheng T. Y., Lin J. T., Chen L. T., Shun C. T., Wang H. P., Lin M. T., Wang T. E., Cheng A. L., Wu M. S. Association of T-cell regulatory gene polymorphisms with susceptibility to gastric mucosa-associated lymphoid tissue lymphoma. J Clin Oncol 2006; 24(21)3483–3489
   PubMed Web of Science ®Google Scholar
• Cesarman E., Chang Y., Moore P. S., Said J. W., Knowles D. M. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. New Engl J Med 1995; 332(18)1186–1191
   PubMed Web of Science ®Google Scholar
• Soulier J., Grollet L., Oksenhendler E., Cacoub P., Cazals-Hatem D., Babinet P., d'Agay M. F., Clauvel J. P., Raphael M., Degos L., Sigaux F. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease. Blood 1995; 86(4)1276–1280
   PubMed Web of Science ®Google Scholar
• Fakhari F. D., Jeong J. H., Kanan Y., Dittmer D. P. The latency-associated nuclear antigen of Kaposi sarcoma-associated herpesvirus induces B cell hyperplasia and lymphoma. J Clin Investig 2006; 116(3)735–742
   PubMed Web of Science ®Google Scholar
• Immunization, Vaccines and Biologicals. World Health Organization, Geneva 2006
   Google Scholar
• Hepatitis C fact sheet. Centers for Disease Control and Prevention, Atlanta 2006
   Google Scholar
• Luppi M., Longo G., Ferrari M. G., Ferrara L., Marasca R., Barozzi P., Morselli M., Emilia G., Torelli G. Additional neoplasms and HCV infection in low-grade lymphoma of MALT type. Br J Haematol 1996; 94(2)373–375
   PubMed Web of Science ®Google Scholar
• De Vita S., Sacco C., Sansonno D., Gloghini A., Dammacco F., Crovatto M., Santini G., Dolcetti R., Boiocchi M., Carbone A., Zagonel V. Characterization of overt B-cell lymphomas in patients with hepatitis C virus infection. Blood 1997; 90(2)776–782
   PubMed Web of Science ®Google Scholar
• Talamini R., Montella M., Crovatto M., Dal Maso L., Crispo A., Negri E., Spina M., Pinto A., Carbone A., Franceshi S. Non-Hodgkin lymphoma and hepatitis C virus: a case-control study from northern and southern Italy. Int J Cancer 2004; 110(3)380–385
   PubMed Web of Science ®Google Scholar
• Gisbert J. P., Garcia-Buey L., Pajares J. M., Moreno-Otero R. Prevalence of hepatitis C virus infection in B-cell Hodgkin lymphoma: systematic review and meta analysis. Gastroenterology 2003; 125(6)1723–1732
   PubMed Web of Science ®Google Scholar
• Cowgill K. D., Loffredo C. A., Eissa S A, Makhtar N, Abdel-Mamid M, Fahmy A, Strickland G T. Case-control study of non-Hodgkin lymphoma and hepatitis C virus infection in Egypt. Int J Epidemiol 2004; 33(5)1034–1039
   PubMed Web of Science ®Google Scholar
• Morton L. M., Engels E. A., Holford T. R., Leaderer B., Zhang Y., Zahm S. H., Boyle P., Zhang B., Flynn S., Tallini G., Owens P. H., Zheng T., Hepatitis C. virus and risk of non-Hodgkin lymphoma; a population based case-control study among Connecticut women. Cancer Epidemiol Biomarkers Prev 2004; 13(3)425–430
   PubMed Web of Science ®Google Scholar
• Engels E. A., Chatterjee N., Cerhan J. R., Davis S., Cozen W., Severson R. K., Whitby D., Colt J. S., Hartge P. Hepatitis C virus infection and non-Hodgkin lymphoma: results of the NCI-SEER multi-center case-control study. Int J Cancer 2004; 111(1)76–80
   PubMed Web of Science ®Google Scholar
• Suarez F., Lortholary O., Hermine O., Lecuit M. Infection-associated lymphomas derived from marginal zone B cells: a model of antigen-driven lymphoproliferation. Blood 2006; 107(8)3034–3044
   PubMed Web of Science ®Google Scholar
• Vilchez R. A., Madden C. R., Kozinetz C. A., Halvorson S. J., White Z. S., Jorgensen J. L., Finch C. J., Butel J. S. Association between simian virus 40 and non-Hodgkin lymphoma. Lancet 2002; 359(9309)817–823
   PubMed Web of Science ®Google Scholar
• Shivapurkar N., Harad K., Reddy J., Scheuermann R. H., Xu Y., McDenna R. W., Michgrub S., Kroft S. H., Feng Z., Gasdar A. F. Presence of simian virus 40 DNA sequences in human lymphomas. Lancet 2002; 359(9309)851–852
   PubMed Web of Science ®Google Scholar
• Rizzo P., Carbone M., Fisher S. G., Matker C., Swinnen L. J., Powers A., Di Resta I., Alkan S., Pass H. I., Fisher R. I. Simian virus 40 is present in most United States human mesothliomas, but it is rarely present in non-Hodgkin lymphoma. Chest 1999; 116: 470S–473S, (6 Suppl)
   PubMed Web of Science ®Google Scholar
• David H., Mendoza S., Konishi T., Miller C. Simian virus 40 is present in human lymphomas and normal blood. Cancer Lett 2001; 162(1)57–64
   PubMed Web of Science ®Google Scholar
• Engels E. A., Viscidi R. P., Galloway D. A., Carter J. J., Cerhan J. R., Davis S., Cozen W., Severson R. K., de Sanjose S., Colt J. S., Hartge P. Case-control study of simian virus 40 and non-Hodgkin lymphoma in the United States. J Natl Cancer Inst 2004; 96(18)1368–1374
   PubMed Web of Science ®Google Scholar
• Willemze R., Kerl H., Sterry W., Berti E., Cerroni L., Chimenti S., Diaz-Peréz J. L., Geerts M. L., Goos M., Knobler R., Ralfkiaer E., Santucci M., Smith N., Wechsler J., van Vloten W. A., Meijer C. J. EORTC classification for primary cutaneous lymphomas: a proposal from the cutaneous lymphoma study group of the European Organization for Research and Treatment of Cancer. Blood 1997; 90(1)354–371
   PubMed Web of Science ®Google Scholar
• Lecuit M., Abachin E., Martin A., Poyart C., Pochart P., Suarez F., Bengoufa D., Feuillard J., Lavergne A., Gordon J. I., Berche P., Guillevin L., Lortholary O. Immunoproliferative Small Intestinal Disease Associated with Campylobacter jejuni. N Eng J Med 2004; 350(3)239–248
   PubMed Web of Science ®Google Scholar
• Ferreri A. J., Guidoboni M., Ponzoni M., De Conciliis C., Dell'Oro S., Fleischhauer K., Caggiari L., Lettini A. A., Dal Cin E., Ieri R., Freschi M., Villa E., Boiocchi M., Dolcetti R. Evidence for an association between Chlamydia psittaci and ocular adnexal lymphomas. J Natl Cancer Inst 2004; 96(8)586–594
   PubMed Web of Science ®Google Scholar
• Tavani A., La Vecchia C., Franceschi S., Serraino D., Carbone A. Medical history and risk of Hodgkin and non-Hodgkin lymphomas. Eur J Cancer Prev 2000; 9(1)59–64
   PubMed Web of Science ®Google Scholar
• Hartge P., Devesa S. S., Grauman D., Fears T. R., Fraumeni J. F. Non-Hodgkin lymphoma and sunlight. J Natl Cancer Inst 1996; 88(5)298–300
   PubMed Web of Science ®Google Scholar
• Hartge P., Lim U., Freedman D. M., Colt J. S., Cerhan J. R., Cozen W., Severson R. K., Davis S. Ultraviolet radiation, dietary vitamin D, and risk of non-Hodgkin lymphoma (United States). Cancer Causes Control 2006; 17(8)1045–1052
   PubMed Web of Science ®Google Scholar
• Zheng T., Mayne S. T., Boyle P., Holford T. R., Liu W. L., Flannery J. Epidemiology of non-Hodgkin lymphoma in Connecticut. 1935–1988. Cancer 1992; 70(4)840–849
   PubMed Web of Science ®Google Scholar
• Adami J., Frisch M., Yuen J., Glimelius B., Melbye M. Evidence of an association between non-Hodgkin lymphoma and skin cancer. BMJ 1995; 310(6993)1491–1495
   PubMed Web of Science ®Google Scholar
• Kripke M. L. Ultraviolet radiation and immunology: something new under the sun—presidential address. Cancer Res 1994; 54(23)6102–6105
   PubMed Web of Science ®Google Scholar
• Hughes A. M., Armstrong B. K., Vajdic C. M., Turner J., Grulich A., Fritschi L., Milliken S., Kaldor J., Benke G., Kricker A. Pigmentary characteristics, sun sensitivity and non-Hodgkin lymphoma. Int J Cancer 2004; 110(3)429–434
   PubMed Web of Science ®Google Scholar
• Melbye M., Adami H. O., Hjalgrim H., Glimelius B. Ultraviolet light and non-Hodgkin lymphoma. Acta Oncol 1996; 35(6)655–728
   PubMed Web of Science ®Google Scholar
• McMichael A. J., Giles G. G. Have increases in solar ultraviolet exposure contributed to the rise in incidence of non-Hodgkin lymphoma?. Br J Cancer 1996; 73(7)945–950
   PubMed Web of Science ®Google Scholar
• Smedby K. E., Hjalgrim H., Melbye M., Torrång A., Rostgaard K., Munksgaard L., Adami J., Hansen M., Porwit-MacDonald A., Jensen B. A., Roos G., Pedersen B. B., Sundström C., Glimelius B., Adami H. O. Ultraviolet radiation exposure and risk of malignant lymphomas. J Natl Cancer Inst 2005; 97(3)199–209
   PubMed Web of Science ®Google Scholar
• Miligi L., Costantini A. S., Bolejack V., Veraldi A., Benvenuti A., Nanni O., Ramazzotti V., Tumino R., Stagnaro E., Rodella S., Fontana A., Vindigni C., Vineis P. Non-Hodgkin lymphoma, leukemia, and exposures in agriculture: results from the Italian multicenter case-control study. Am J Ind Med 2003; 44(6)627–636
   PubMed Web of Science ®Google Scholar
• Blair A., Zahm S. H. Cancer among farmers. Occup Med 1991; 6(3)335–354
   PubMedGoogle Scholar
• D'Amore F., Hasle H., Hansen K. S. Occupational exposures and non-Hodgkin lymphoma. Hematol Rev 1992; 6: 183–199
   Google Scholar
• De Roos A. J., Zahm S. H., Weisenburger D. D., Holmes F. F., Burmeister L. F., Blair A. Integrative assessment of multiple pesticides as risk factors for non-Hodgkin lymphoma among men. Occup Environ Med 2003; 60(9)E11
   PubMed Web of Science ®Google Scholar
• McDuffie H. H., Pahwa P., McLaughlin J. R., Spinelli J. J., Fincham S., Dosman J. A., Robson D., Skinnider L. F., Choi N. W. Non-Hodgkin lymphoma and specific pesticide exposures in men: cross-Canada study of pesticides and health. Cancer Epidemiol Biomarkers Prev 2001; 10(11)1155–1163
   PubMed Web of Science ®Google Scholar
• Quintana P. J., Delfino R. J., Korrick S., Ziogas A., Kutz F. W., Jones E. L., Laden F., Garshick E. Adipose tissue levels of organochlorine pesticides and polychlorinated biphenyls and risk of non-Hodgkin lymphoma. Environ Health Perspect 2004; 112(8)854–861
   PubMed Web of Science ®Google Scholar
• Pearce N. Phenoxy herbicides and non-Hodgkin lymphoma in New Zealand: frequency and duration of herbicide use. Br J Ind Med 1989; 46(2)143–144
   PubMedGoogle Scholar
• Institute of Medicine. Veterans and Agent Orange. National Academy Press, Washington, D. C 2000, Update
   Google Scholar
• Hoar S. K., Blair A., Holmes F. F. Agricultural herbicide use and risk of lymphoma and soft-tissue sarcoma. JAMA 1986; 256(9)1141–1147
   PubMed Web of Science ®Google Scholar
• Zahm S. H., Weisenburger D. D., Babbitt P. A. A case-control study of non-Hodgkin lymphoma and the herbicide 2,4-dichlorophenoxyacetic acid (2,4-D) in eastern Nebraska. Epidemiology 1990; 1(5)349–356
   PubMedGoogle Scholar
• Wigle D. T., Semenciw R. M., Wilkins K., Riedel D., Ritter L., Morrison H. I., Mao Y. Mortality study of Canadian male farm operators: non-Hodgkin lymphoma mortality and agricultural practices in Saskatchewan. J Natl Cancer Inst 1990; 82(7)575–582
   PubMed Web of Science ®Google Scholar
• Figgs L. W., Holland N. T., Rothmann N., Zahm S. H., Tarone R. E., Hill R., Vogt R. F., Smith M. T., Boysen C. D., Holmes F. F., VanDyck K., Blair A. Increased lymphocyte replicative index following 2,4-dichlorophenoxyacetic acid herbicide exposure. Cancer Causes Control 2000; 11(4)373–380
   PubMed Web of Science ®Google Scholar
• Pimental D., McLaughlin L., Zepp A. Handbook of Pest Management in Agriculture, Vol. 1. CRC Press, Boca Raton 1993
   Google Scholar
• Hayes H. M., Tarone R. E., Cantor K. P. Case-control study of canine malignant lymphoma: positive association with dog owner's use of 2,4-dichlorophenoxyacetic acid herbicides. J Natl Cancer Inst 1991; 83(17)1226–1231
   PubMed Web of Science ®Google Scholar
• Rothman N., Cantor K. P., Blair A., Bush D., Brook J. W., Helzlsouer K., Zahm S. H., Needham L., Pearson G. R., Hoover R. N., Comstock G. W., Strickland P. T. A nested case-control study of non-Hodgkin lymphoma and serum organochlorine residues. Lancet 1997; 350(9073)240–244
   PubMed Web of Science ®Google Scholar
• Cantor K. P., Strickland P. T., Brock J. W., Bush D., Helzlsouer K., Needham L. L., Zahm S. H., Comstock G. W., Rothman N. Risk of non-Hodgkin lymphoma and prediagnostic serum organochlorines: β-hexachlorocyclohexane, chlordane/heptachlor-related compounds, dieldrin, and hexachlorobenzene. Environ Health Perspect 2003; 111(2)179–183
   PubMed Web of Science ®Google Scholar
• Blair A., Hartge P., Stewart P. A., McAdams M., Lubin J. Mortality and cancer incidence of aircraft maintenance workers exposed to trichloroethylene and other organic solvents and chemicals: extended follow up. Occup Environ Med 1998; 55(3)161–171
   PubMed Web of Science ®Google Scholar
• Boice J. D., Marano D. E., Fryzek J. P., Sadler C. J., McLaughlin J. K. Mortality among aircraft manufacturing workers. Occup Environ Med 1999; 56(9)581–597
   PubMed Web of Science ®Google Scholar
• Hayes R. B., Yin S. N., Dosemeci M., Li G. L., Wacholder S., Travis L. B., Li C. Y., Rothman N., Hoover R. N., Linet M. S. Benzene and the dose-related incidence of hematologic neoplasms in China. Chinese Academy of Preventive Medicine–National Cancer Institute Benzene Study Group. J Natl Cancer Inst 1997; 89(14)1065–1071
   PubMed Web of Science ®Google Scholar
• Fritschi L., Benke G., Hughes A. M., Kricker A., Vajdic C. M., Grulich A., Turner J., Milliken S., Kaldor J., Armstrong B. K. Risk of non-Hodgkin lymphoma associated with occupational exposure to solvents, metals, organic dust, and PCBs (Australia). Cancer Causes Control 2005; 16(5)599–607
   PubMed Web of Science ®Google Scholar
• Some aromatic amines and related nitro compounds – hair dyes, colouring agents and miscellaneous industrial chemicals. International Agency for Research on Cancer monographs on the evaluation of carcinogenic risks to humans, monograph 16. IARC Press, Lyon 1978
   Google Scholar
• Zhang Y., Holford T. R., Leaderer B., Boyle P., Zahm S. H., Flynn S., Tallini G., Owens P. H., Zheng T. Hair-coloring product use and risk of non-Hodgkin lymphoma: a population-based case-control study in Connecticut. Am J Epidemiol 2004; 159(2)148–154
   PubMed Web of Science ®Google Scholar
• Holly E. A., Lele C., Bracci P. M. Hair color products and risk for non-Hodgkin lymphoma: a population-based study in the San Francisco bay area. Am J Public Health 1998; 88(12)1767–1773
   PubMed Web of Science ®Google Scholar
• Altekruse S. F., Henley S. J., Thun M. J. Deaths from hematopoietic and other cancers in relation to permanent hair dye use in a large prospective study (United States). Cancer Causes Control 1999; 10(6)617–625
   PubMed Web of Science ®Google Scholar
• Grodstein F., Hennekens C. H., Colditz G. A., Hunter D. J., Stampfer M. J. A prospective study of permanent hair dye use and hematopoietic cancer. J Natl Cancer Inst 1994; 86(19)1466–1470
   PubMed Web of Science ®Google Scholar
• Cantor K. P., Blair A., Everett G., VanLier S., Burmeister L., Dick F. R., Gibson R. W., Schuman L. Hair dye use and risk of leukemia and lymphoma. Am J Public Health 1988; 78(5)570–571
   PubMed Web of Science ®Google Scholar
• Zahm S. H., Weisenburger D. D., Babbitt P. A., Saal R. C., Vaught J. B., Blair A. Use of hair coloring products and the risk of lymphoma, multiple myeloma, and chronic lymphocytic leukemia. Am J Public Health 1992; 82(7)990–997
   PubMed Web of Science ®Google Scholar
• de Sanjosé S., Benavente Y., Nieters A., Foretova L., Maynadié M., Cocco P. L., Staines A., Vornanen M., Boffetta P., Becker N., Alvaro T., Brennan P. Association between personal use of hair dyes and lymphoid neoplasms in Europe. Am J Epidemiol 2006; 164(1)47–55
   PubMed Web of Science ®Google Scholar
• Cerhan J. R., Wallace R. B., Folsom A. R., Potter J. D., Munger R. G., Prineas R. J. Transfusion history and cancer risk in older women. Ann Intern Med 1993; 119(1)8–15
   PubMed Web of Science ®Google Scholar
• Blomberg J., Möller T., Olsson H., Anderson H., Jonsson M. Cancer morbidity in blood recipients–results of a cohort study. Eur J Cancer 1993; 29A(15)2101–2105
   PubMed Web of Science ®Google Scholar
• Memon A., Doll R. A search for unknown blood-borne oncogenic viruses. Int J Cancer 1994; 58(3)366–368
   PubMed Web of Science ®Google Scholar
• Cerhan J. R., Wallace R. B., Dick F., Kemp J., Parker A. S., Zheng W., Sellers T. A., Folsom A. R. Blood transfusions and risk of non-Hodgkin lymphoma subtypes and chronic lymphocytic leukemia. Cancer Epidemiol Biomarkers Prev 2001; 10(4)361–368
   PubMed Web of Science ®Google Scholar
• Opelz G., Sengar D. P., Mickey M. R., Terasaki P. I. Effect of blood transfusions on subsequent kidney transplants. Transplant Proc 1973; 5(1)253–259
   PubMed Web of Science ®Google Scholar
• Klein H. G. Immunomodulatory aspects of transfusion: a once and future risk?. Anesthesiology 1999; 91(3)861–865
   PubMed Web of Science ®Google Scholar
• Landers D. F., Hill G. E., Wong K. C., Fox I. J. Blood transfusion-induced immunomodulation. Anesth Analg 1996; 82(1)187–204
   PubMed Web of Science ®Google Scholar
• Chow E. J., Holly E. A. Blood transfusions as a risk factor for non-Hodgkin lymphoma in the San Francisco Bay Area: a population-based study. Am J Epidemiol 2002; 155(8)725–731
   PubMed Web of Science ®Google Scholar
• Chow E. J., Holly E. A. Blood transfusions and non-Hodgkin lymphoma. Epidemiol Rev 2002; 24(2)269–279
   PubMed Web of Science ®Google Scholar
• Zhang Y., Holford T. R., Leaderer B., Boyle P., Zahm S. H., Owens P. H., Morton L. M., Zhang B., Zou K., Flynn S., Tallini G., Zheng T. Blood transfusion and risk of non-Hodgkin lymphoma in Connecticut women. Am J Epidemiol 2004; 160(4)325–330
   PubMed Web of Science ®Google Scholar
• Chiu B. C., Cerhan J. R., Folsom A. R., Sellers T. A., Kushi L. H., Wallace R. B., Zheng W., Potter J. D. Diet and risk of non-Hodgkin lymphoma in older women. JAMA 1996; 275(17)1315–1321
   PubMed Web of Science ®Google Scholar
• Ward M. H., Zahm S. H., Weisenburger D. D., Gridley G., Cantor K. P., Saal R. C., Blair A. Dietary factors and non-Hodgkin lymphoma in Nebraska (United States). Cancer Causes Control 1994; 5(5)422–432
   PubMed Web of Science ®Google Scholar
• De Stefani E., Fierro L., Barrios E., Ronco A. Tobacco, alcohol, diet and risk of non-Hodgkin lymphoma: a case-control study in Uruguay. Leuk Res 1998; 22(5)445–452
   PubMed Web of Science ®Google Scholar
• Zhang S., Hunter D. J., Rosner B. A., Colditz G. A., Fuchs C. S., Speizer F. E., Willett W. C. Dietary fat and protein in relation to risk of non-Hodgkin lymphoma among women. J Natl Cancer Inst 1999; 91(20)1751–1758
   PubMed Web of Science ®Google Scholar
• Zheng T., Holford T. R., Leaderer B., Zhang Y., Zahm S. H., Flynn S., Tallini G., Zhang B., Zhou K., Owens P. H., Lan Q., Rothman N., Boyle P. Diet and nutrient intakes and risk of non-Hodgkin lymphoma in Connecticut women. Am J Epidemiol 2004; 159(5)454–466
   PubMed Web of Science ®Google Scholar
• Chiu B. C., Weisenburger D. D. An update of the epidemiology of non-Hodgkin lymphoma. Clin Lymphoma 2003; 4(3)161–168
   PubMedGoogle Scholar
• Kelemen L. E., Cerhan J. R., Lim U., Davis S., Cozen W., Schenk M., Colt J., Hartge P., Ward M. H. Vegetables, fruit, and antioxidant-related nutrients and risk of non-Hodgkin lymphoma: a National Cancer Institute—Surveillance, Epidemiology, and End Results population-based case-control study. Am J Clin Nutr 2006; 83(6)1401–1410
   PubMed Web of Science ®Google Scholar
• Zhang S. M., Giovannucci E. L., Hunter D. J., Rimm E. B., Ascherio A., Colditz G. A., Speizer F. E., Willett W. C. Vitamin supplement use and the risk of non-Hodgkin lymphoma among women and men. Am J Epidemiol 2001; 153(11)1056–1063
   PubMed Web of Science ®Google Scholar
• Friedman A., al-Sabbagh A., Santos L. M., Fishman-Lobell J., Polanski M., Das M. P., Khoury S. J., Weiner H. L. Oral tolerance: a biologically relevant pathway to generate peripheral tolerance against external and self antigens. Chemical Immunol 1994; 58: 259–290
   PubMed Web of Science ®Google Scholar
• Schwartz R. S. Another look at immunologic surveillance. N Eng J Med 1975; 293(4)181–184
   PubMedGoogle Scholar
• Hummell D. S. Dietary lipids and immune function. Prog Food Nutr Sci 1993; 17(4)287–329
   PubMedGoogle Scholar
• Fritschi L., Ambrosini G. L., Kliewer E. V., Johnson K. C., Canadian Cancer Registries Epidemiology Research Group. Dietary fish intake and risk of leukaemia, multiple myeloma and non-Hodgkin lymphoma. Cancer Epid Biomarkers Prev 2004; 13(4)532–537
   PubMed Web of Science ®Google Scholar
• Fritschi L., Johnson K. C., Kliewer E. V., Fry R. Canadian Cancer Registries Epidemiology Research Group. Animal-related occupations and the risk of leukaemia, myeloma, and non-Hodgkin lymphoma in Canada. Cancer Causes Control 2002; 13(6)563–571
   PubMedGoogle Scholar
• Hyman G. A., Sommers S. C. The development of Hodgkin disease and lymphoma during anticonvulsant therapy. Blood 1996; 28(3)416–427
   Google Scholar
• Abbondazo S. L., Irey N. S., Frizzera G. Dilantin-associated lymphadenopathy. Spectrum of histopathological patterns. Am J Surg Pathol 1995; 19(6)675–686
   PubMed Web of Science ®Google Scholar
• Choi T. S., Doh K. S., Kim S. H., Jang M. S., Suh K. S., Kim S. T. Clinicopathological and genotypic aspects of anticonvulsant-induced pseudolymphoma syndrome. Br J Dermatol 2003; 148(4)730–736
   PubMed Web of Science ®Google Scholar
• Ploysangam T., Breneman D. L., Mutasim D. F. Cutaneous pseudolymphomas. J Am Acad Dermatol 1998; 38: 877–895, (6 Pt 1)
   PubMed Web of Science ®Google Scholar
• Magro C. M., Crowson A. N. Drug-induced immune dysregulation as a cause of atypical cutaneous lymphoid infiltrates: a hypothesis. Hum Pathol 1996; 27(2)125–32
   PubMed Web of Science ®Google Scholar
• Magro C. M., Crowson A. N., Kovatich A. J., Burns F. Drug-induced reversible lymphoid dyscrasia: a clonal lymphomatoid dermatitis of memory and activated T cells. Hum Pathol 2003; 34(2)119–129
   PubMed Web of Science ®Google Scholar
• Nihal M., Mikkola D., Horvath N., Gilliam A. C., Stevens S. R., Spiro T. P., Cooper K. D., Wood G. S. Cutaneous lymphoid hyperplasia: a lymphoproliferative continuum with lymphomatous potential. Hum Pathol 2003; 34(6)617–622
   PubMed Web of Science ®Google Scholar
• Kwak B., Mulhaupt F., Myit S., Mach F. Statins as a newly recognized type of immunomodulator. Nat Med 2000; 6(12)1399–1402
   PubMed Web of Science ®Google Scholar
• Youssef S., Stüve O., Patarroyo J. C., Ruiz P. J., Radosevich J. L., Hur E. M., Bravo M., Mitchell D. J., Sobel R. A., Steinman L., Zamvil S. S. The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease. Nature 2002; 420(6911)78–84
   PubMed Web of Science ®Google Scholar
• Weitz-Schmidt G., Welzenbach K., Brinkmann V., Kamata T., Kallen J., Bruns C., Cottens S., Takada Y., Hommel U. Statins selectively inhibit leukocyte function antigen-1 by binding to a novel regulatory integrin site. Nat Med 2001; 7(6)687–692
   PubMed Web of Science ®Google Scholar
• Cornacchia E., Golbus J., Maybaum J., Strahler J., Hanash S., Richardson B. Hydralazine and procainamide inhibit T cell DNA methylation and induce autoreactivity. J Immunol 1988; 140(7)2197–2200
   PubMed Web of Science ®Google Scholar